Literature DB >> 18431245

Incidence, predictors, and outcomes of cardiac pacing after cardiac transplantation: an 11-year retrospective analysis.

Gregory W Woo1, Richard S Schofield, Daniel F Pauly, James A Hill, Jamie B Conti, Jordana Kron, Charles T Klodell, Ramanjeet Singh, Juan M Aranda.   

Abstract

More than 20% of cardiac transplant patients go on to require permanent pacing. We sought to determine the incidence of cardiac pacing in our cardiac transplant population and identify characteristics that may predict which patients will require permanent pacing. We reviewed medical records of cardiac transplant recipients and compared baseline characteristics of patients who received pacemakers with those of patients who did not receive pacemakers. Of 292 patients included in this analysis, 71 (24%) required permanent posttransplant pacing. Use of amiodarone before transplant was associated with a nonsignificant trend toward needing a pacemaker after transplant (P=0.08). Patients undergoing biatrial anastomosis were more likely to require permanent pacing than patients undergoing bicaval anastomosis (P<0.001). Approximately one fourth of cardiac transplant patients require permanent pacing. Surgical technique is a major predictor of who will require permanent pacing after cardiac transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18431245     DOI: 10.1097/TP.0b013e31816b677c

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

Review 1.  Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.

Authors:  Douglas L Jennings; Brandon Martinez; Sheila Montalvo; David E Lanfear
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Pacemaker Use Following Heart Transplantation.

Authors:  Hari R Mallidi; Michael Bates
Journal:  Ochsner J       Date:  2017

3.  Permanent pacing in a very long-term follow-up after orthotopic heart transplantation: A matter of when or why?

Authors:  Emyal Alyaydin; Christian Pogoda; Angelo Dell'Aquila; Gerrit Frommeyer; Juergen R Sindermann; Holger Reinecke; Izabela Tuleta
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-06-07       Impact factor: 1.485

4.  Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.

Authors:  Lauren B Cooper; Robert J Mentz; Leah B Edwards; Amber R Wilk; Joseph G Rogers; Chetan B Patel; Carmelo A Milano; Adrian F Hernandez; Josef Stehlik; Lars H Lund
Journal:  J Heart Lung Transplant       Date:  2016-07-17       Impact factor: 10.247

5.  Risk factors and survival of patients with permanent pacemaker implantation after heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Philipp Ehlermann; Hugo A Katus; Edgar Zitron
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

6.  Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Hugo A Katus; Andreas O Doesch
Journal:  Drug Des Devel Ther       Date:  2017-06-19       Impact factor: 4.162

7.  Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post-transplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Philipp Ehlermann; Hugo A Katus; Edgar Zitron
Journal:  ESC Heart Fail       Date:  2020-07-01

Review 8.  Genetic Complexity of Sinoatrial Node Dysfunction.

Authors:  Michael J Wallace; Mona El Refaey; Pietro Mesirca; Thomas J Hund; Matteo E Mangoni; Peter J Mohler
Journal:  Front Genet       Date:  2021-04-01       Impact factor: 4.599

9.  Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation.

Authors:  Stefan Roest; Olivier C Manintveld; Marit A E Kolff; Ferdi Akca; Jesse F Veenis; Alina A Constantinescu; Jasper J Brugts; Ozcan Birim; Lennie M van Osch-Gevers; Tamas Szili-Torok; Kadir Caliskan
Journal:  ESC Heart Fail       Date:  2022-02-17

10.  Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival.

Authors:  Salman S Allana; Furqan A Rajput; Jason W Smith; Lucian Lozonschi; Jinn-Ing Liou; Maryl Johnson; Takushi Kohmoto; Ravi Dhingra
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-19       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.